FMC Corporation (NYSE:FMC) agreed to acquire an unknown majority stake in BioPhero ApS from Novo Holdings A/S and others for approximately $200 million on June 29, 2022. The purchase price of approximately $200 million will be paid at closing. FMC Ventures, the corporate investment arm of FMC Corporation (NYSE:FMC) already held a minority stake prior to this transaction. The acquisition is subject to regulatory approvals and satisfaction of customary closing conditions. The acquisition of BioPhero is expected to be completed by the end of the third quarter 2022.